Autonomic Nervous System - Part 1: Sympathetic System
Overview of the Nervous System
- General Functions: The nervous system functions to control and coordinate the activity of every system within the body.
- Control Mechanisms: It operates through both involuntary and voluntary control mechanisms.
- Two Major Subdivisions:
- Central Nervous System (CNS):
- Composition: Composed of the brain and the spinal cord.
- Function: Receives and interprets sensory information and initiates the appropriate motor responses.
- Peripheral Nervous System (PNS):
- Afferent Nerves: These carry sensory impulses toward the CNS.
- Efferent Nerves: These carry motor impulses away from the CNS to the rest of the body.
- Cranial Nerves: Consists of 12 pairs.
- Spinal Nerves: Consists of 31 pairs.
Functional Divisions of the Peripheral Nervous System
- Somatic Nervous System (SNS):
- Anatomy: The nerves branch from cranial and spinal motor nerves.
- Target: Innervates skeletal muscle.
- Control: Responsible for voluntary control mediated by the cerebral cortex.
- Autonomic Nervous System (ANS) - Visceral:
- Anatomy: Branches of cranial and spinal motor nerves.
- Target: Innervates cardiac muscle, smooth muscle of internal organs, and glands.
- Control: Involuntary control regulated by the hypothalamus and the medulla oblongata.
- Autorhythmicity: The capacity for contraction without any external stimulus.
- Homeostasis: The ANS regulates the rate at which internal organs work by increasing or decreasing their activity to maintain a stable internal environment.
Structure and Synaptic Transmission of the ANS
- Ganglia: These are collections of synapses where impulses travel from one neuron to the next. They serve as the junction between preganglionic and postganglionic nerves.
- Preganglionic Nerve: This nerve fiber emerges directly from the spinal cord.
- Postganglionic Nerve: This nerve fiber travels from the ganglion to the target internal organ or gland.
- Neurotransmitters (NT): Chemical substances that keep the impulse going. They stimulate the internal organ or gland to produce a specific action or change by binding to specialized receptors.
- Synaptic Arrangement by Division:
- In both the Sympathetic and Parasympathetic divisions, the neurotransmitter released at the autonomic ganglion from the preganglionic fiber is Acetylcholine (ACH).
- Parasympathetic Division: The postganglionic nerve fiber is cholinergic and releases ACH at the target organ.
- Sympathetic Division: The postganglionic nerve fiber is adrenergic and releases Norepinephrine (NE) at the target organ.
Subdivisions of the Autonomic Nervous System
- Sympathetic Nervous System:
- Commonly referred to as the "Fight, Fright, or Flight" system.
- Categorized as the Adrenergic system.
- Parasympathetic Nervous System:
- Commonly referred to as the "Rest and Digest" system.
- Categorized as the Cholinergic system.
- Dual Innervation: Most organs and glands receive nerves from both divisions to provide balanced regulation, with blood vessels being a notable exception (innervated primarily by the sympathetic system).
The Sympathetic Nervous System (Adrenergic System)
- Primary Function: Regulates the activity of internal organs and glands during physical and mental stressful situations (focusing on the heart, brain, and lungs).
- Energy Consumption: Involves the exertion of a large amount of physical and mental energy.
- Body-Wide Response: A single neuron can act on many others; therefore, the whole body is typically stimulated simultaneously rather than just a single part.
- Triggers: Daily stresses, illness, anxiety, and crisis situations.
- Ganglionic Structure: The sympathetic ganglia are located far from the effector organs (closer to the spinal cord).
- Endocrine Function: The adrenal medulla releases Epinephrine (EPI) and some Norepinephrine (NE) into the bloodstream to travel to receptor sites and produce systemic sympathetic responses.
Adrenergic Neurotransmitters and Synthesis
- Acetylcholine (ACH): Cholinergic neurotransmitter released at the ganglia from presynaptic nerve endings in both the sympathetic and parasympathetic systems.
- Norepinephrine (NE):
- The primary adrenergic neurotransmitter released at postganglionic nerve endings.
- Synthesized from Dopamine (DA).
- Released by both neurons and the adrenal medulla.
- Epinephrine (EPI):
- Produced primarily by the adrenal medulla.
- Acts on adrenergic receptors throughout the body.
- Dopamine (DA):
- Serves as a neurotransmitter in both the sympathetic system and the CNS.
- Acts as the precursor to Norepinephrine (NE).
- Stimulates multiple receptors including alpha, beta, and dopaminergic receptors; its specific actions are dose-dependent.
- Synthesis Pathway:
- Tyrosine (Tyr) is taken up into the nerve ending.
- Tyrosine is enzymatically converted to dihydroxyphenylalanine (DOPA).
- DOPA is converted to Dopamine (DA).
- DA enters storage vesicles where it is synthesized into and stored as Norepinephrine (NE).
- Fate of Norepinephrine after Release:
- NE is released into the synaptic cleft upon adrenergic stimulation.
- It can stimulate adrenergic receptors on target organs/glands.
- It can stimulate alpha2 receptors on the postganglionic nerve ending to inhibit further NE release (negative feedback).
- It can undergo reuptake back into the nerve ending for restorage in vesicles or metabolism by Monoamine Oxidase (MAO) into inactive metabolites.
Detailed Classification of Adrenergic Receptors
- Alpha-1 (alpha1):
- Location: Glands, smooth muscles, eyes, and most arteries and veins.
- Effects: Smooth muscle contraction, vasoconstriction (leading to increased BP), and dilation of the pupils (mydriasis).
- Stimulants: NE and EPI (catecholamines).
- Alpha-2 (alpha2):
- Location: Adrenergic nerve endings.
- Effects: Relaxation and inhibition. It produces a parasympathetic-like response by decreasing smooth muscle contraction (vasodilation, lowering BP).
- Mechanism: Acts as a negative feedback system to decrease or regulate the release of NE.
- Beta-1 (beta1):
- Location: Primarily the heart.
- Effects:
- Positive Inotropic effect: Increased force of contraction.
- Positive Chronotropic effect: Increased heart rate.
- Positive Dromotropic effect: Increased conduction velocity.
- Stimulants: NE and EPI (EPI has a stronger effect).
- Beta-2 (beta2):
- Location: Smooth muscle, lungs (bronchioles), uterus, skeletal muscle arteries, and coronary arteries.
- Effects:
- Smooth muscle relaxation.
- Bronchodilation.
- Uterine relaxation.
- Vasodilation of coronary and skeletal muscle blood vessels.
- Stimulants: Stimulated by EPI only; NE does not stimulate beta-2 receptors.
Physiologic Effects of Sympathetic Stimulation
- Adrenal Medulla: Release of Epinephrine.
- Arteries: General vasoconstriction. Exceptions include coronary arteries and skeletal muscle arteries, which undergo dilation via beta2 receptors.
- Heart: Increased heart rate, increased AV conduction, and increased contractility.
- Gastrointestinal (GI): Decreased GI motility and reduced secretions.
- Eyes: Contraction of the iris muscle resulting in pupillary dilation (mydriasis).
- Respiratory Passages: Bronchodilation.
- Urinary System: Relaxation of the urinary bladder and contraction of the urinary sphincter, which decreases urination.
- Metabolism: Conversion of glycogen to glucose to provide energy for use.
Sympathetic Effects on Blood Vessels and Vasomotor Tone
- Vasoconstriction: Triggered by a high rate of sympathetic nerve firing. This increases blood pressure but reduces regional blood flow.
- Vasodilation: Triggered by a low rate of sympathetic nerve firing (causing smooth muscle relaxation). This decreases blood pressure but increases blood flow through the vessels.
- Note: BP is also regulated by other systems in the body besides vasomotor tone.
Pharmacology of the Sympathetic Nervous System
- Sympathomimetic Effects: Occur when drugs mimic the sympathetic system. These are also known as adrenergics or adrenergic agonists.
- Sympatholytic Effects: Occur when drugs work against the sympathetic system. These are known as adrenergic blocking drugs, adrenergic blockers, inhibitors, or antagonists.
Alpha-1 Adrenergic Agonists
- Mechanism of Action (MOA): Stimulates the alpha1 receptor, leading to smooth muscle contraction and vasoconstriction.
- Clinical Uses:
- Increasing circulation to vital organs.
- Increasing blood pressure.
- Decongestion (vasoconstriction of nasal passages shrinks swollen mucous membranes).
- Cautions/Side Effects: Potential for excessive vasoconstriction in hypertensive or cardiac patients; slows digestion and urination; causes excessive nasal dryness.
General Adrenergic Agonists (e.g., Epinephrine)
- MOA: Stimulates alpha1, beta1, and beta2 receptors.
- Clinical Profile: Functions as a vasopressor (increases BP), cardiac stimulant, and bronchodilator.
- Uses: Severe allergic reactions (anaphylaxis), shock, and cardiac arrhythmias.
- Examples: EpiPen Auto-Injectors (0.3 mg).
Alpha-1 Adrenergic Blocking Drugs
- MOA: Binds to and blocks alpha1 receptors, causing relaxation of smooth muscle and vasodilation.
- Uses: Hypertension (HTN) and Benign Prostatic Hyperplasia (BPH) by increasing urine flow through ureter relaxation.
- Suffix: Commonly end in "-azosin".
- Side Effects: Orthostatic hypotension (caution with position changes), reflex tachycardia, GI upset, and increased urination.
Beta-1 Adrenergic Agonists
- Dose-Dependent MOA:
- Low Dose: Stimulates dopaminergic (D1) receptors in kidneys, causing vasodilation and increased renal blood flow.
- Moderate Dose: Stimulates beta1 receptors in the heart to increase contraction force and cardiac output.
- High Dose: Stimulates alpha1 receptors causing vasoconstriction and increased blood pressure.
- Uses: Shock, acute heart failure.
- Example: Dobutamine (250,mg/20,mL).
- Side Effects: Cardiac overstimulation and CNS irritation.
Beta-2 Adrenergic Agonists
- MOA: Stimulates beta2 receptors to relax smooth muscle in the lungs and uterus.
- Uses: Asthma, respiratory disease, and preterm labor.
- Side Effects: Tachycardia, jitteriness, tremors, and headache.
Beta Blocking Drugs (Beta Blockers)
- Suffix: Commonly end in "-olol".
- Selective Beta-1 Blockers:
- MOA: Block beta1 receptors. Produces negative inotropic (contraction), negative chronotropic (rate), and negative dromotropic (conduction) effects.
- Uses: HTN, angina, arrhythmias, tachycardia, migraines, glaucoma (lowers IOP), and heart failure.
- Non-selective Beta Blockers:
- MOA: Block both beta1 and beta2 receptors.
- Contraindication: Asthma and respiratory disease patients (can cause bronchoconstriction via beta2 blockade and trigger respiratory distress).
- General Side Effects: Drowsiness, GI upset, CNS depression, bradycardia, mental depression; must monitor serum lipid levels and glucose levels in diabetics.